GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Easton Biopharmaceuticals Co Ltd (SHSE:688513) » Definitions » PEG Ratio

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) PEG Ratio : 2.98 (As of May. 26, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chengdu Easton Biopharmaceuticals Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Chengdu Easton Biopharmaceuticals Co's PE Ratio without NRI is 29.17. Chengdu Easton Biopharmaceuticals Co's 5-Year EBITDA growth rate is 9.80%. Therefore, Chengdu Easton Biopharmaceuticals Co's PEG Ratio for today is 2.98.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Chengdu Easton Biopharmaceuticals Co's PEG Ratio or its related term are showing as below:

SHSE:688513' s PEG Ratio Range Over the Past 10 Years
Min: 0.96   Med: 1.18   Max: 3.06
Current: 2.98


During the past 8 years, Chengdu Easton Biopharmaceuticals Co's highest PEG Ratio was 3.06. The lowest was 0.96. And the median was 1.18.


SHSE:688513's PEG Ratio is ranked worse than
64.86% of 111 companies
in the Biotechnology industry
Industry Median: 1.49 vs SHSE:688513: 2.98

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Chengdu Easton Biopharmaceuticals Co PEG Ratio Historical Data

The historical data trend for Chengdu Easton Biopharmaceuticals Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Easton Biopharmaceuticals Co PEG Ratio Chart

Chengdu Easton Biopharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial - - 1.58 2.61 -

Chengdu Easton Biopharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Chengdu Easton Biopharmaceuticals Co's PEG Ratio

For the Biotechnology subindustry, Chengdu Easton Biopharmaceuticals Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chengdu Easton Biopharmaceuticals Co's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Easton Biopharmaceuticals Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Chengdu Easton Biopharmaceuticals Co's PEG Ratio falls into.



Chengdu Easton Biopharmaceuticals Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Chengdu Easton Biopharmaceuticals Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=29.174832387829/9.80
=2.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Chengdu Easton Biopharmaceuticals Co  (SHSE:688513) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Chengdu Easton Biopharmaceuticals Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Chengdu Easton Biopharmaceuticals Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Headlines

No Headlines